Results 61 to 70 of about 591,975 (259)

Vitamin D supplementation in systemic lupus erythematosus patients with vitamin D deficiency and insufficiency : the effect on disease activity, fatigue and interferon signature gene expression [PDF]

, 2019
Background: Vitamin D deficiency is highly prevalent among patients with systemic lupus erythematosus (SLE) [1]. Evidence from multiple studies has shown that vitamin D deficiency in SLE is associated with a higher disease activity [2].
Borg, Andrew, Camilleri, Liberato, Magro, Rosalie, Saliba, Christian, Scerri, Christian   +4 more
core   +1 more source

Failure to achieve lupus low disease activity state (LLDAS) six months after diagnosis is associated with early damage accrual in Caucasian patients with systemic lupus erythematosus [PDF]

, 2017
Background: The aim was to assess the attainability and outcome of the lupus low disease activity state (LLDAS) in the early stages of systemic lupus erythematosus (SLE).
CAPPELLAZZO, GIULIA, Cauli, Alberto, Chessa, Elisabetta, Congia, Mattia, Floris, Alberto, Mathieu, Alessandro, Piga, Matteo   +6 more
core   +1 more source

AB0636 FREQUENCY OF TROPICAL INFECTIONS IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS IN A MEDIUM INCOME COUNTRY, USING DATA ANALYTICS TECHNIQUES [PDF]

, 2023
Adriana Beltrán-Ostos, Sergio Moreno‐Jiménez, J. S. Castro Villarreal, C. F. Valencia Arboleda   +3 more
openalex   +1 more source

The Structure of Molecular Clouds: II - Column Density and Mass Distributions [PDF]

, 2010
The formation of stars is inextricably linked to the structure of their parental molecular clouds. Here we take a number of nearby giant molecular clouds (GMCs) and analyse their column density and mass distributions.
Alves, Ballesteros-Paredes, Bally, Boldyrev, Cambrésy, Carpenter, Dirk Froebrich, Dobashi, Froebrich, Froebrich, Froebrich, Goodman, Hartmann, Johnstone, Jonathan Rowles, Kainulainen, Kenyon, Klessen, Knude, Kolmogorov, Kun, Lada, Lada, Lombardi, Lombardi, Motte, Muench, Padoan, Rowles, Schlegel, She, Skrutskie, Straižys, Vázquez-Semadeni   +33 more
core   +2 more sources

AB0534 TREATING SYSTEMIC LUPUS ERYTHEMATOSUS IN THE 21ST CENTURY: COMBINING RITUXIMAB WITH BELIMUMAB [PDF]

, 2023
B. Issayeva, A. A. Mesnyankina, Е. А. Асеева, S. Solovyev, N. Yu. Nikishina, S. Issayeva, M. M. Saparbayeva, A. Amanzholova, Ardak Razikhova, A. Аbdulgaziz   +9 more
openalex   +1 more source

IgG anti-apolipoprotein A-1 antibodies in patients with systemic lupus erythematosus are associated with disease activity and corticosteroid therapy: an observational study. [PDF]

, 2015
IgG anti-apolipoprotein A-1 (IgG anti-apoA-1) antibodies are present in patients with systemic lupus erythematosus (SLE) and may link inflammatory disease activity and the increased risk of developing atherosclerosis and cardiovascular disease (CVD) in ...
Alber, KF, Bassett, P, Chambers, S, Croca, S, Davari, M, Giles, I, Ioannou, Y, Isenberg, D, Leach, O, Rahman, A   +9 more
core   +1 more source

Enhanced Medullary and Extramedullary Granulopoiesis Sustain the Inflammatory Response in Lupus Nephritis [PDF]

, 2023
Eleni Zervopoulou, Maria Grigoriou, Stavros Doumas, Danae Yiannakou, Pavlos Pavlidis, Gilles Gasparoni, Jörn Walter, Anastasia Filia, Harikleia Gakiopoulou, Aggelos Banos, Ioannis Mitroulis, Dimitrios T. Boumpas   +11 more
openalex   +1 more source

A review of studies of the proteomes of circulating microparticles: key roles for galectin-3-binding protein-expressing microparticles in vascular diseases and systemic lupus erythematosus

Clinical Proteomics, 2017
Subcellular microvesicles (MVs) have attracted increasing interest during the past decades. While initially considered as inert cellular debris, several important roles for MVs in physiological homeostasis, cancer, cardiovascular, and autoimmune diseases
Christoffer T. Nielsen, Ole Østergaard, Niclas S. Rasmussen, Søren Jacobsen, Niels H. H. Heegaard   +4 more
doaj   +1 more source

Spartan Daily, May 9, 2018 [PDF]

, 2018
Volume 150, Issue 42https://scholarworks.sjsu.edu/spartan_daily_2018/1041/thumbnail ...
San Jose State University, School of Journalism and Mass Communications
core   +2 more sources

A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases

ACR Open Rheumatology
Chimeric antigen receptor (CAR) T‐cell therapy, long transformative in oncology, is now rapidly emerging as a frontier in autoimmune rheumatic diseases, particularly systemic lupus erythematosus (SLE), driven by accumulating evidence of deep B‐cell ...
Roberto Caricchio, Stacie Bell, Sasha Bernatsky, Maria Dall'Era, David Goddard, Kenneth Kalunian, Alfred H. J. Kim, Fotios Koumpouras, Jose Rubio, Amit Saxena, Saira Sheikh, the Lupus Clinical Investigators Network   +11 more
doaj   +1 more source